{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T01:13:29Z","timestamp":1790039609703,"version":"4.0.1"},"update-to":[{"DOI":"10.1002\/14651858.cd007449","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2015,8,26]],"date-time":"2015-08-26T00:00:00Z","timestamp":1440547200000}}],"reference-count":35,"publisher":"Wiley","issue":"8","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd007449.pub2","type":"journal-article","created":{"date-parts":[[2015,8,26]],"date-time":"2015-08-26T10:38:36Z","timestamp":1440585516000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Blood pressure lowering efficacy of dual alpha and beta blockers for primary hypertension"],"prefix":"10.1002","volume":"2015","author":[{"given":"Gavin WK","family":"Wong","sequence":"first","affiliation":[{"name":"University of British Columbia; Department of Anesthesiology, Pharmacology and Therapeutics; 2176 Health Sciences Mall Vancouver BC Canada V6T 1Z3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Laugerotte","sequence":"additional","affiliation":[{"name":"University of British Columbia; Department of Anesthesiology, Pharmacology and Therapeutics; 2176 Health Sciences Mall Vancouver BC Canada V6T 1Z3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M","family":"Wright","sequence":"additional","affiliation":[{"name":"University of British Columbia; Department of Anesthesiology, Pharmacology and Therapeutics; 2176 Health Sciences Mall Vancouver BC Canada V6T 1Z3"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2015,8,26]]},"reference":[{"key":"10.1002\/14651858.CD007449.pub2-BIB0001|cit1","unstructured":"GlaxoSmithKline A multicenter, double-blind, placebo-controlled comparison of Carvedilol (SK&F) 6.25 mg, 12.5 mg, and 25.0 mg administered twice daily in patients with mild and moderate hypertension. http:\/\/www.gsk-clinicalstudyregister.com\/result_detail.jsp?protocolId=105517%2F021&studyId=80A0B2AA-C084-4ACF-8FA7-23C564527CF2&compound=carvedilol (accessed - day month year)"},{"key":"10.1002\/14651858.CD007449.pub2-BIB0002|cit2","unstructured":"GlaxoSmithKline A multicenter, double-blind, placebo-controlled comparison of carvedilol (SK&F 105517) 6.25mg, 12.5mg, 25mg, and 50mg administered once daily in patients with mild to moderate hypertension. http:\/\/www.gsk-clinicalstudyregister.com\/result_detail.jsp?protocolId=105517%2F022&studyId=CD325C8A-3EBC-4621-91DE-C403E8D28CFD&compound=carvedilol (accessed day month year )"},{"key":"10.1002\/14651858.CD007449.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1136\/bmj.1.6017.1046","article-title":"Combined alpha- and beta-adrenoceptor blockade with labetalol in hypertension","volume":"1","author":"Frick","year":"1976","journal-title":"British Medical Journal"},{"key":"10.1002\/14651858.CD007449.pub2-BIB0004|cit4","first-page":"737","article-title":"A double blind trial of labetalol","volume":"Suppl","author":"Kane","year":"1976","journal-title":"British Journal of Clinical Pharmacology"},{"key":"10.1002\/14651858.CD007449.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/BF00548395","article-title":"Clinical evaluation of labetalol alone and combined with chlorthalidone in essential hypertension: a double blind multicenter controlled study","volume":"22","author":"Lechi","year":"1982","journal-title":"European Journal of Clinical Pharmacology"},{"issue":"Suppl 6","key":"10.1002\/14651858.CD007449.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"82","DOI":"10.2165\/00003495-198800366-00015","article-title":"Effect of Carvedilol on Blood pressure in patients with mild to moderate hypertension. A dose response study","volume":"36","author":"McPhillips","year":"1988","journal-title":"Drugs"},{"issue":"4","key":"10.1002\/14651858.CD007449.pub2-BIB0007|cit7","first-page":"253","article-title":"Effect of 400 mg\/day labetalol on lipids, lipoproteins and apoproteins in hypertensive patients","volume":"34","author":"Rouffy","year":"1986","journal-title":"Pathologie Biologie"},{"key":"10.1002\/14651858.CD007449.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"32L","DOI":"10.1016\/j.amjcard.2006.07.017","article-title":"Controlled Release Carvedilol in the treatment of essential hypertension","volume":"98 Suppl","author":"Weber","year":"2006","journal-title":"American Journal of Cardiology"},{"key":"10.1002\/14651858.CD007449.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"S130","DOI":"10.1097\/00005344-198706111-00024","article-title":"Effect of carvedilol on ambulatory blood pressure, renal hemodynamics, and cardiac function in essential hypertension","volume":"10 Suppl 11","author":"Dupont","year":"1987","journal-title":"Journal of Cardiovascular Pharmacology"},{"key":"10.1002\/14651858.CD007449.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"626","DOI":"10.5694\/j.1326-5377.1979.tb119425.x","article-title":"Labetalol and bendrofluazide: comparison of their antihypertensive effects","volume":"1","author":"Horvath","year":"1979","journal-title":"Medical Journal of Australia"},{"key":"10.1002\/14651858.CD007449.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00546699","article-title":"Propranolol vs metoprolol vs labetalol: A comparative study in essential hypertension","volume":"26","author":"Kubik","year":"1984","journal-title":"European Journal of Clinical Pharmacology"},{"issue":"6134","key":"10.1002\/14651858.CD007449.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1136\/bmj.2.6134.383","article-title":"Randomised study of six beta-blockers and a thiazide diuretic in essential hypertension","volume":"2","author":"Wilcox","year":"1978","journal-title":"British Medical Journal"},{"issue":"1","key":"10.1002\/14651858.CD007449.pub2-BIB0013|cit13","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007185.pub2","article-title":"Blood pressure lowering efficacy of beta-blockers as second-line therapy for primary hypertension","author":"Chen","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"8","key":"10.1002\/14651858.CD007449.pub2-BIB0014|cit14","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003654.pub4","article-title":"Calcium channel blockers versus other classes of drugs for hypertension","author":"Chen","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD007449.pub2-BIB0015|cit15","unstructured":"Canadian Pharmacist Association e-Therapeutics Available from https:\/\/www.e-therapeutics.ca\/cps.showMonograph.action (accessed October 2012) 2012"},{"key":"10.1002\/14651858.CD007449.pub2-BIB0016|cit16","unstructured":"U.S. Food Drug Administration FDA Online Label Repository Available from http:\/\/labels.fda.gov\/ (accessed May 2013) 2013"},{"key":"10.1002\/14651858.CD007449.pub2-BIB0017|cit17","first-page":"188","article-title":"Chapter 8: Neurotransmission: The Autonomic and Somatic Motor Nervous Systems","volume-title":"Goodman & Gilman's The Pharmacological Basis of Therapeutics","author":"Westfall","year":"2011"},{"issue":"4","key":"10.1002\/14651858.CD007449.pub2-BIB0018|cit18","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003823.pub2","article-title":"Blood pressure lowering efficacy of angiotensin converting enzyme (ACE) inhibitors for primary hypertension","author":"Heran","year":"2008","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD007449.pub2-BIB0019|cit19","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003822.pub2","article-title":"Blood pressure lowering efficacy of angiotensin receptor blockers for primary hypertension","author":"Heran","year":"2008","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD007449.pub2-BIB0020|cit20","unstructured":"Higgins JPT Green S Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD007449.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: Is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Controlled Clinical Trials"},{"key":"10.1002\/14651858.CD007449.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1161\/CIRCULATIONAHA.104.529628","article-title":"Headaches and the treatment of blood pressure results from a meta-analysis of 94 randomized placebo-controlled trials with 24 000 participants","volume":"112","author":"Law","year":"2005","journal-title":"Circulation"},{"issue":"1","key":"10.1002\/14651858.CD007449.pub2-BIB0023|cit23","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002863","article-title":"Oral beta-blockers for mild to moderate hypertension during pregnancy","author":"Magee","year":"2003","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD007449.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"232","DOI":"10.2165\/00003495-199345020-00006","article-title":"Carvedilol: A review of its pharmacodynamic, pharmacokinetic properties and therapeutic efficacy","volume":"45","author":"McTavish","year":"1993","journal-title":"Drugs"},{"issue":"4","key":"10.1002\/14651858.CD007449.pub2-BIB0025|cit25","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007066.pub2","article-title":"Blood pressure lowering efficacy of renin inhibitors for primary hypertension","author":"Musini","year":"2008","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD007449.pub2-BIB0026|cit26","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000028.pub2","article-title":"Pharmacotherapy for hypertension in the elderly","author":"Musini","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"5","key":"10.1002\/14651858.CD007449.pub2-BIB0027|cit27","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003824.pub2","article-title":"Blood pressure-lowering efficacy of monotherapy with thiazide diuretics for primary hypertension","author":"Musini","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD007449.pub2-BIB0028|cit28","unstructured":"Thomas K Breaking the Seal on Drug Research Available from: http:\/\/www.nytimes.com\/2013\/06\/30\/business\/breaking-the-seal-on-drug-research.html?hp&_r=1& (accessed 14 October 2014)"},{"issue":"1","key":"10.1002\/14651858.CD007449.pub2-BIB0029|cit29","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002003.pub2","article-title":"Beta blockers for hypertension","author":"Wiysonge","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD007449.pub2-BIB0030|cit30","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007451","article-title":"Blood pressure lowering efficacy of beta-1 selective beta blockers for primary hypertension","author":"Wong","year":"2008","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD007449.pub2-BIB0031|cit31","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007452.pub2","article-title":"Blood pressure lowering efficacy of nonselective beta-blockers for primary hypertension","author":"Wong","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"11","key":"10.1002\/14651858.CD007449.pub2-BIB0032|cit32","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007450.pub2","article-title":"Blood pressure lowering efficacy of partial agonist beta blocker monotherapy for primary hypertension","author":"Wong","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD007449.pub2-BIB0033|cit33","first-page":"188","article-title":"Choosing a first-line drug in the management of elevated blood pressure: What is the evidence? 2: \u03b2-Blockers","volume":"163","author":"Wright","year":"2000","journal-title":"CMAJ: Canadian Medical Association Journal"},{"issue":"3","key":"10.1002\/14651858.CD007449.pub2-BIB0034|cit34","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001841.pub2","article-title":"First-line drugs for hypertension","author":"Wright","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD007449.pub2-BIB0035|cit35","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008170.pub2","article-title":"First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension","author":"Xue","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD007449.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,22]],"date-time":"2022-06-22T13:17:48Z","timestamp":1655903868000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD007449.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Hypertension Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,8,26]]},"references-count":35,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2015,8]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd007449.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,26]]}}}